Corp Cytrx is 10% at RXI PHARMACEUTICALS CORP (RXII). They have made 4 open-market trades across 1 company since 2009, most recently 2010-12-29.
CIK 0000799698
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RXII | 2,593,881 | — |
Shares reported on the most recent Form 4, priced at the 2010-12-23 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RXII | SELL · 10b5-1 | 2010-12-29 | 2010-12-30 | $2.20 | $5.7M | N/A | N/A | N/A |
| RXII | SELL | 2010-12-22 | 2010-12-23 | $2.65 | $1.3M | N/A | N/A | N/A |
| RXII | SELL | 2010-06-30 | 2010-07-02 | $2.55 | $5.1M | N/A | N/A | N/A |
| RXII | SELL | 2010-03-26 | 2010-07-02 | $5.70 | $3.8M | N/A | N/A | N/A |
| RXII | SELL | 2009-09-23 | 2009-09-25 | $2.50 | $1.3M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.